Cargando…
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
IL-1 belongs to a family of 11 members and is one of the seven receptor-agonists with pro-inflammatory activity. Beyond its biological role as a regulator of the innate immune response, IL-1 is involved in stress and chronic inflammation, therefore it is responsible for several pathological conditio...
Autores principales: | Gelfo, Valerio, Romaniello, Donatella, Mazzeschi, Martina, Sgarzi, Michela, Grilli, Giada, Morselli, Alessandra, Manzan, Beatrice, Rihawi, Karim, Lauriola, Mattia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503335/ https://www.ncbi.nlm.nih.gov/pubmed/32825489 http://dx.doi.org/10.3390/ijms21176009 |
Ejemplares similares
-
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
por: Romaniello, Donatella, et al.
Publicado: (2022) -
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
por: Romaniello, Donatella, et al.
Publicado: (2023) -
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
por: Ferlizza, Enea, et al.
Publicado: (2023) -
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
por: Mazzeschi, Martina, et al.
Publicado: (2022) -
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies
por: Gelfo, Valerio, et al.
Publicado: (2019)